Ya Hong Pharmaceuticals (688176.SH) announced its half-yearly financial results, with a net loss attributable to the parent company of 162 million yuan.

The China Fortune Financial News APP reported that Aohong Pharmaceuticals (688176.SH) disclosed its interim report for the first half of 2025. During the reporting period, the company achieved revenue of 130 million yuan, a year-on-year increase of 61.80%; the net loss attributable to the parent company was 162 million yuan; the non-recurring net profit was a loss of 177 million yuan; and the basic earnings per share was -0.29 yuan.